These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31978446)

  • 1. A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice.
    Guo Q; Xu S; Yang P; Wang P; Lu S; Sheng D; Qian K; Cao J; Lu W; Zhang Q
    J Control Release; 2020 Apr; 320():347-362. PubMed ID: 31978446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease.
    Wang P; Zheng X; Guo Q; Yang P; Pang X; Qian K; Lu W; Zhang Q; Jiang X
    J Control Release; 2018 Jun; 279():220-233. PubMed ID: 29679667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-neuron targeted nanoparticles for peptide synergy therapy at dual-target of Alzheimer's disease.
    Guo Q; Li Y; Xu S; Wang P; Qian K; Yang P; Sheng D; Wang L; Cheng Y; Meng R; Cao J; Luo H; Wei Y; Zhang Q
    J Control Release; 2023 Mar; 355():604-621. PubMed ID: 36738970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloid plaque targeting in Alzheimer's disease mice.
    Zheng X; Pang X; Yang P; Wan X; Wei Y; Guo Q; Zhang Q; Jiang X
    Acta Biomater; 2017 Feb; 49():388-401. PubMed ID: 27845275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.
    Zhang C; Zheng X; Wan X; Shao X; Liu Q; Zhang Z; Zhang Q
    J Control Release; 2014 Oct; 192():317-24. PubMed ID: 25102404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-functional nanoparticles for precise drug delivery to Alzheimer's disease lesions: Targeting mechanisms, pharmacodynamics and safety.
    Zheng X; Zhang C; Guo Q; Wan X; Shao X; Liu Q; Zhang Q
    Int J Pharm; 2017 Jun; 525(1):237-248. PubMed ID: 28432017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte membrane-coated nanocarriers modified by TGN for Alzheimer's disease.
    Gu J; Yan C; Yin S; Wu H; Liu C; Xue A; Lei X; Zhang N; Geng F
    J Control Release; 2024 Feb; 366():448-459. PubMed ID: 38128884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice.
    Zhang C; Wan X; Zheng X; Shao X; Liu Q; Zhang Q; Qian Y
    Biomaterials; 2014 Jan; 35(1):456-65. PubMed ID: 24099709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide.
    Liu Z; Gao X; Kang T; Jiang M; Miao D; Gu G; Hu Q; Song Q; Yao L; Tu Y; Chen H; Jiang X; Chen J
    Bioconjug Chem; 2013 Jun; 24(6):997-1007. PubMed ID: 23718945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
    Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
    Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides.
    Li J; Zhang C; Li J; Fan L; Jiang X; Chen J; Pang Z; Zhang Q
    Pharm Res; 2013 Jul; 30(7):1813-23. PubMed ID: 23549751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease.
    Gao C; Chu X; Gong W; Zheng J; Xie X; Wang Y; Yang M; Li Z; Gao C; Yang Y
    J Nanobiotechnology; 2020 May; 18(1):71. PubMed ID: 32404183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
    Gu J; Chen X; Fang X; Sha X
    Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Dual Targeting Drug Delivery System for Penetrating Blood-Brain Barrier and Selectively Delivering siRNA to Neurons for Alzheimer's Disease Treatment.
    Zhang C; Gu Z; Shen L; Liu X; Lin H
    Curr Pharm Biotechnol; 2017; 18(14):1124-1131. PubMed ID: 29484985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
    Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
    Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB.
    Chen C; Duan Z; Yuan Y; Li R; Pang L; Liang J; Xu X; Wang J
    ACS Appl Mater Interfaces; 2017 Feb; 9(7):5864-5873. PubMed ID: 28128553
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.